Online citations, reference lists, and bibliographies.
← Back to Search

Assessment Of Stereotactic Radiosurgery Treatment Response For Brain Metastases Using MRI Based Diffusion Index

Zengai Chen, J. Zu, Lei Li, Xiaojie Lu, Jianming Ni, J. Xu
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Introduction To investigate the clinical predictive values of the apparent diffusion coefficient (ADC) as a biomarker in radiation response of brain metastases. Method Forty-one patients with brain metastases treated with stereotactic radiosurgery (SRS) were imaged at baseline, one month post SRS, and six months post SRS using diffusion weighted MRI. The mean of ADC for metastases and tumor volume was calculated. A diffusion index (DI) was generated using the sum of 1/ADC among all the voxels in a tumor. Tumor response status was determined by lesion volume measured at six month post-SRS, or the last available follow-up MRI. Logistic regression analysis was used to account for factors associated with tumor response at baseline and one month post SRS. Results A higher ADC mean distinguished responders from non-responders only at six month post SRS (p < 0.05). However, a lower DI distinguished a responder from non-responders on the baseline, one month post SRS and six months post SRS, indicating better diagnostic performance of the DI with regard to a non-invasive biomarker in monitoring SRS treatment response. A multivariate logistic regression analysis identified the DI as a predictor of tumor response at baseline and one month post SRS (p = 0.002 and p = 0.001, respectively). However, logistic regression analysis identified the ADC mean as a predictor of tumor response only at six months post SRS (p = 0.019). Conclusion Our results support the hypothesis that ADC and tumor volume generated DT at baseline, one month and six months post SRS may be a promising biomarker predicting brain metastases’ response. Specifically, a lower DI at baseline and one month distinguished responders from non-responders.
This paper references
10.3171/JNS/2008/109/8/0259
Stereotactic drainage and Gamma Knife radiosurgery of cystic brain metastasis.
A. Franzin (2008)
10.1093/JNCI/92.24.2029
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
T. Chenevert (2000)
10.1016/S0730-725X(97)00178-1
Serial MR imaging of intracranial metastases after radiosurgery.
H. Hawighorst (1997)
10.1007/s10334-004-0079-z
Diffusion imaging for evaluation of tumor therapies in preclinical animal models
B. Moffat (2004)
10.1016/J.JAMCOLLSURG.2004.02.024
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
J. Guillem (2004)
10.3109/0284186X.2012.681066
Volume specific response criteria for brain metastases following salvage stereotactic radiosurgery and associated predictors of response
M. Follwell (2012)
10.1016/J.SURNEU.2007.02.021
Diffusion magnetic resonance imaging as an evaluation of the response of brain metastases treated by stereotactic radiosurgery.
C. Huang (2008)
10.1148/RADIOL.2343031721
Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats.
H. Thoeny (2005)
10.1593/NEO.81328
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.
A. Padhani (2009)
10.1007/s00259-008-0936-5
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer
K. Ho (2008)
10.1148/radiol.2471070567
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
U. Tateishi (2008)
Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma.
H. Nakamura (2000)
10.1007/s11307-010-0433-7
Quantitative Assessment of Diffusion-Weighted MR Imaging in Patients with Primary Rectal Cancer: Correlation with FDG-PET/CT
J. Gu (2010)
Abrey, Current management of metastatic brain disease, Neurotherapeutics
L.E.T. Ranjan (2009)
10.2214/AJR.167.4.8819370
Analysis of interobserver and intraobserver variability in CT tumor measurements.
K. Hopper (1996)
Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats, Radiology
H. C. Thoeny (2005)
10.2214/AJR.177.4.1770919
MR imaging of pituitary adenomas after gamma knife stereotactic radiosurgery.
G. Tung (2001)
10.2967/jnumed.108.058461
18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
C. Costelloe (2009)
10.1016/j.cmpb.2005.08.004
DtiStudio: Resource program for diffusion tensor computation and fiber bundle tracking
H. Jiang (2006)
10.1016/j.nurt.2009.04.012
Current management of metastatic brain disease
T. Ranjan (2011)
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations, Neoplasia
A. R. Padhani (2009)
10.3171/FOC.2000.9.2.6
Current treatment of patients with multiple brain metastases.
S. Chang (2000)
10.1093/jnci/92.3.205
New Guidelines to Evaluate the Response to Treatment in Solid Tumors.
P. Therasse (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
P. Therasse (2000)
10.1016/S1470-2045(09)70263-3
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L. Chang (2009)
10.1148/RADIOLOGY.211.3.R99JN48807
MR imaging response of brain metastases after gamma knife stereotactic radiosurgery.
A. M. Peterson (1999)
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
T. Chenevert (1997)
10.1016/S0098-1672(09)79041-1
Bone Metastases in Patients with Metastatic Breast Cancer: Morphologic and Metabolic Monitoring of Response to Systemic Therapy with Integrated PET/CT
B. Manaster (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar